Baxter International Inc. (BAX)

NYSE: BAX · Real-Time Price · USD
21.76
-6.29 (-22.42%)
At close: Jul 31, 2025, 4:00 PM
21.75
-0.01 (-0.05%)
After-hours: Jul 31, 2025, 7:47 PM EDT
-22.42%
Market Cap11.16B
Revenue (ttm)10.89B
Net Income (ttm)-155.00M
Shares Out 512.97M
EPS (ttm)-0.30
PE Ration/a
Forward PE8.62
Dividend$0.68 (3.13%)
Ex-Dividend DateAug 29, 2025
Volume47,020,208
Open23.76
Previous Close28.05
Day's Range21.47 - 24.16
52-Week Range21.47 - 40.49
Beta0.60
AnalystsBuy
Price Target36.38 (+67.19%)
Earnings DateJul 31, 2025

About SWTX

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technolog... [Read more]

Sector Healthcare
Founded 1931
Employees 38,000
Stock Exchange NYSE
Ticker Symbol BAX
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for BAX stock is "Buy." The 12-month stock price target is $36.38, which is an increase of 67.19% from the latest price.

Price Target
$36.38
(67.19% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Hospital Product Maker Baxter Stock Plunges On Trimmed Annual Outlook

Q2 adjusted EPS was $0.59, matching guidance but slightly below the $0.61 Street estimate. FY25 EPS forecast lowered to $2.42–$2.52 vs. prior range of $2.47–$2.55.

6 hours ago - Benzinga

Baxter International Inc. (BAX) Q2 2025 Earnings Call Transcript

Baxter International Inc. (NYSE:BAX) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair &...

7 hours ago - Seeking Alpha

Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit

Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the lingering effect of Hurricane Helene, which damaged a key manufacturing fa...

10 hours ago - Reuters

Baxter Reports Second-Quarter 2025 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025. “For the second quarter of 2025, Baxter delivere...

12 hours ago - Business Wire

Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter

IRVING, Texas--(BUSINESS WIRE)--Vizient announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter.

8 days ago - Business Wire

Baxter the Brave Mouse Unites Baxterville Against the Cat Pack

Baxter, a brave mouse from Baxterville, faces the Cat Pack's mischief in a heartwarming tale of friendship and forgiveness from Palmetto Publishing. Baxter, a brave mouse from Baxterville, faces the C...

9 days ago - GlobeNewsWire

Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31, ...

14 days ago - Business Wire

Baxter Declares Quarterly Dividend

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share o...

17 days ago - Business Wire

Medical Equipment Maker Baxter International Names New CEO

Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new CEO.

24 days ago - Investopedia

Baxter International Names Andrew Hider as CEO

Baxter International said on Monday that Andrew Hider will take over as the medical device maker's new Chief Executive Officer.

24 days ago - Reuters

Baxter Appoints Andrew Hider Chief Executive Officer

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a m...

24 days ago - Business Wire

Baxter Publishes Annual Corporate Responsibility Report, Demonstrating Ongoing Action to Make a Meaningful Difference Around the World

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2024 Corporate Responsibility Report. The annual report demonstrates Baxter's commi...

5 weeks ago - Business Wire

Mountain Heating and Cooling Transforms Historic Baxter Hotel with Innovative Mitsubishi Heat Pump Installation

Bozeman, June 11, 2025 (GLOBE NEWSWIRE) -- Bozeman, Montana - Mountain Heating and Cooling recently shared details about their Mitsubishi Heat Pump Installation at the Historic Baxter Hotel in Bozeman...

7 weeks ago - GlobeNewsWire

BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10, 20...

2 months ago - Business Wire

The 'Goldilocks' Case For Baxter International

Baxter International's stock has been challenging to own for the past decade, initially due to high valuations and later due to execution concerns and an ugly acquisition. During the pandemic, health ...

3 months ago - Seeking Alpha

Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript

Baxter International Inc. (NYSE:BAX) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President and Chief Investor Relations Officer Brent Sh...

3 months ago - Seeking Alpha

Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps

On Thursday, Baxter International Inc. BAX reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.

3 months ago - Benzinga

Baxter tops quarterly estimates on strong demand for medical devices

Medical products maker Baxter International on Thursday beat Wall Street estimates for first-quarter revenue and profit, helped by the robust demand for its intravenous (IV) solutions and patient-moni...

3 months ago - Reuters

Baxter Reports First-Quarter 2025 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2025. “Our solid performance in the first quarter of 20...

3 months ago - Business Wire

Baxter to Present at Bank of America Securities 2025 Health Care Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Jo...

3 months ago - Business Wire

Goldman's John Marshall provides stock opportunities ahead of earning season

John Marshall, Goldman Sachs head of derivatives research, joins 'Money Movers' to discuss the current market environment, individual companies Goldman looked at, and much more.

Other symbols: ANETMOPGRTWLOWWD
3 months ago - CNBC Television

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery

VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature st...

4 months ago - Business Wire

Baxter to Host Annual Meeting of Stockholders in Virtual Format

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2025 Annual Meeting) in a virtual format on Tuesday, ...

4 months ago - Business Wire

Stocks beating the stock market's recent Trump slump have this in common

This year's top performer among the S&P 500 has been CVS Health's stock, which had a bad 2024 and is cheap by a key valuation measure.

5 months ago - Market Watch

Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings

LAS VEGAS--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today unveiled Voalte Linq device powered by Scotty assistant, the company's first voice-activated technology...

5 months ago - Business Wire